Indacaterol, a once-daily beta 2 -agonist, versus twice-daily beta 2 -agonists or placebo for chronic obstructive pulmonary disease: Cochrane systematic review

Indacaterol, a once-daily beta 2 -agonist, versus twice-daily beta 2 -agonists or placebo for chronic obstructive pulmonary disease: Cochrane systematic review is a topic covered in the Cochrane Abstracts.

To view the entire topic, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

There's more to see -- the rest of this entry is available only to subscribers.